We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

60 hedge funds and large institutions have $37.2M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more call options, than puts

Call options by funds: $183K | Put options by funds: $47K

4% more capital invested

Capital invested by funds: $35.7M → $37.2M (+$1.52M)

6% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 17

14% less funds holding

Funds holding: 70 → 60 (-10)

83% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 12

Holders
60
Holders Change
-10
Holders Change %
-14.29%
% of All Funds
1.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
16
Reduced
17
Closed
12
Calls
$183K
Puts
$47K
Net Calls
+$136K
Net Calls Change
-$80K

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$6.75M
2
GPP
Great Point Partners
Connecticut
+$1.15M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$249K
4
Goldman Sachs
Goldman Sachs
New York
+$202K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$198K

Top Sellers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
-$750K
2
TC
TFS Capital
Pennsylvania
-$645K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$540K
4
PP
Paloma Partners
Connecticut
-$396K
5
Bank of America
Bank of America
North Carolina
-$307K
Name Holding Trade Value Shares
Change 		Change in
Stake
HK
26
Horizon Kinetics
New York
$95K – – –
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$93K -$23.3K -6 -19%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$79K +$31.1K +8 +53%
Jacobs Levy Equity Management
29
Jacobs Levy Equity Management
New Jersey
$73K -$229K -59 -74%
EAM
30
Evanson Asset Management
California
$71K – – –
Citigroup
31
Citigroup
New York
$71K +$3.89K +1 +5%
State Street
32
State Street
Massachusetts
$54K – – –
CCM
33
Coldstream Capital Management
Washington
$51K – – –
BMM
34
Berkshire Money Management
Massachusetts
$42K – – –
VKH
35
Virtu KCG Holdings
New York
$42K +$35K +9 +300%
Charles Schwab
36
Charles Schwab
California
$39K – – –
Group One Trading
37
Group One Trading
Illinois
$34K -$3.89K -1 -10%
BA
38
BlackRock Advisors
Delaware
$33K – – –
RCM
39
Rotella Capital Management
Washington
$29K +$3.89K +1 +14%
EWM
40
Evercore Wealth Management
New York
$28K -$27.2K -7 -47%
LP
41
LMR Partners
United Kingdom
$25K -$175K -45 -87%
Wells Fargo
42
Wells Fargo
California
$25K +$3.89K +1 +17%
FNT
43
First National Trust
Pennsylvania
$22K – – –
U
44
UBS
Switzerland
$21K -$42.7K -11 -65%
WEC
45
Winslow Evans & Crocker
Massachusetts
$17.7K – – –
NFA
46
Nationwide Fund Advisors
Ohio
$17K – – –
PPSG
47
Princeton Portfolio Strategies Group
New Jersey
$17K – – –
PCM
48
Prelude Capital Management
New York
$16K -$19.4K -5 -50%
BIM
49
BlackRock Investment Management
Delaware
$16K – – –
BMO
50
Beck Mack & Oliver
New York
$13K – – –
1
2
3 4

FRTX Hedge Fund Activity: Q3 2014 in Review

60 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q3 2014, worth a combined $37.2M — up 4.3% from $35.7M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of FRTX and 2 opened new positions — a net loss of 10 holders — while 17 trimmed existing stakes and 16 added.

The largest buyer was RA Capital Management, opening a new position worth an estimated $6.75M. The largest seller was Northern Trust, cutting an estimated $750K.

  • 60 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q3 2014, down from 70 in Q2 2014.
  • Funds reported $37.2M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q3 2014, up 4.3% quarter-over-quarter.
  • 2 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q3 2014 and 12 closed out, a net change of -10 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q3 2014 was RA Capital Management, an estimated $6.75M added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q3 2014 was Northern Trust, an estimated $750K sold.

Based on aggregated 13F filings for Q3 2014.